Sirdás sisdollui
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aiddostahtton
  • Excessive T-cell depletion adv...
  • Čujuhandieđut
  • Deakstadieđáhus
  • Sádde šleađgaboasttain
  • Čálit
  • Doalvvo čujuhusa
    • Doalvun: RefWorks
    • Doalvun: EndNoteWeb
    • Doalvun: EndNote
  • Bissovaš liŋka
Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation.

Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation.

Bibliográfalaš dieđut
Váldodahkkit: Chakraverty, R, Robinson, S, Peggs, K, Kottaridis, P, Watts, M, Ings, S, Hale, G, Waldmann, H, Linch, D, Goldstone, A, Mackinnon, S
Materiálatiipa: Journal article
Almmustuhtton: 2000
  • Oažžasuvvandieđut
  • Govvádus
  • Geahča maid
  • Bargiidšearbma

Geahča maid

  • Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation.
    Dahkki: Chakraverty, R, et al.
    Almmustuhtton: (2001)
  • Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Dahkki: Mackinnon, S, et al.
    Almmustuhtton: (1999)
  • T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
    Dahkki: Hale, G, et al.
    Almmustuhtton: (1988)
  • T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions.
    Dahkki: D'Sa, S, et al.
    Almmustuhtton: (2003)
  • Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.
    Dahkki: Chakraverty, R, et al.
    Almmustuhtton: (2002)

Ozu molssaeavttut

  • Ohcanhistorjá
  • Aiddostahtton ohcu

Viečča lasi

  • Bláđe logahallama
  • Bláđe alfabehtalaš ortnegis
  • Dutkka kanálaid
  • Gursagirjjit
  • Ođatlogahallan

Dárbbašatgo veahki?

  • Ohcanráva
  • Jeara girjerájus
  • DJG:t